195 related articles for article (PubMed ID: 2338244)
1. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N
Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244
[TBL] [Abstract][Full Text] [Related]
2. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
[TBL] [Abstract][Full Text] [Related]
3. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
Manley NR; O'Connell M; Sun W; Speck NA; Hopkins N
J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
[TBL] [Abstract][Full Text] [Related]
4. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
Speck NA; Renjifo B; Hopkins N
J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
[TBL] [Abstract][Full Text] [Related]
5. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
Granger SW; Fan H
J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
[TBL] [Abstract][Full Text] [Related]
6. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
Li Y; Golemis E; Hartley JW; Hopkins N
J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
[TBL] [Abstract][Full Text] [Related]
7. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer.
Speck NA; Baltimore D
Mol Cell Biol; 1987 Mar; 7(3):1101-10. PubMed ID: 3561410
[TBL] [Abstract][Full Text] [Related]
8. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.
Gunther CV; Graves BJ
Mol Cell Biol; 1994 Nov; 14(11):7569-80. PubMed ID: 7935472
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
10. Core-binding factor influences the disease specificity of Moloney murine leukemia virus.
Lewis AF; Stacy T; Green WR; Taddesse-Heath L; Hartley JW; Speck NA
J Virol; 1999 Jul; 73(7):5535-47. PubMed ID: 10364302
[TBL] [Abstract][Full Text] [Related]
11. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
Hanecak R; Pattengale PK; Fan H
J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
[TBL] [Abstract][Full Text] [Related]
12. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.
Hsiang YH; Spencer D; Wang S; Speck NA; Raulet DH
J Immunol; 1993 May; 150(9):3905-16. PubMed ID: 8473739
[TBL] [Abstract][Full Text] [Related]
13. A single mutation in one of the CORE elements of Moloney murine leukemia virus reduced binding of a 42-kDa T lymphoma cell nuclear factor but did not affect lymphomagenesis.
Case RS; Khang YH; Kumar A; Yuen PH
Mol Carcinog; 1990; 3(2):93-102. PubMed ID: 2346587
[TBL] [Abstract][Full Text] [Related]
14. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
Thiesen HJ; Bösze Z; Henry L; Charnay P
J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
[TBL] [Abstract][Full Text] [Related]
15. The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV-TB is mapped to 11 mutations within the U3 region of the long terminal repeat.
Yuen PH; Szurek PF
J Virol; 1989 Feb; 63(2):471-80. PubMed ID: 2783465
[TBL] [Abstract][Full Text] [Related]
16. Virulence in lymphomagenesis is modulated by alterations in proteins binding to CORE and GRE-LVa elements of the MoMuLV enhancer.
Yuen PH; Khang YH; Matherne C
Leukemia; 1992; 6 Suppl 3():76S-82S. PubMed ID: 1602832
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
Manley NR; O'Connell MA; Sharp PA; Hopkins N
J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
Wang S; Wang Q; Crute BE; Melnikova IN; Keller SR; Speck NA
Mol Cell Biol; 1993 Jun; 13(6):3324-39. PubMed ID: 8497254
[TBL] [Abstract][Full Text] [Related]
19. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers.
Wang SW; Speck NA
Mol Cell Biol; 1992 Jan; 12(1):89-102. PubMed ID: 1309596
[TBL] [Abstract][Full Text] [Related]
20. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
Nieves A; Levy LS; Lenz J
J Virol; 1997 Feb; 71(2):1213-9. PubMed ID: 8995644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
